New York’s Department of Financial Services (DFS) has filed insurance fraud charges against opioid manufacturers Teva Pharmaceuticals and Allergan Plc.
According to a statement from Governor Andrew Cuomo, the DFS alleged in its filing that both Teva and Allergan took part in fraudulent marketing and promotional campaigns – campaigns which misrepresented the safety and effectiveness of opioid drugs.
Reuters reached out to both Teva and Allergan for comment, but neither were able to immediately respond.
In 2019, opioid manufacturer Insys Therapeutics paid $195 million to settle civil allegations that it gave kickbacks to physicians and nurses, bribing them to prescribe the company’s own drug Subsys for patients.
